About
Basic Data Updated:
8 days agoMega Fine Pharma Private Limited has been involved in the production and trade of APIs (Active Pharmaceutical Ingredients) and advanced intermediates, as well as providing CRAMS (Contract Research and Manufacturing Services) to both innovators and global generic pharmaceutical companies. The company boasts two backward integrated manufacturing units, located in Vapi, Gujarat and Nashik, Maharashtra. These units specialize in the production of intermediate and API plants, respectively. MFPPL's product range includes mirtazapine and pyrantel pamoate, as well as various piperazine derivatives. With a diverse portfolio of products, the company caters to a wide range of therapeutic areas such as CNS (Central Nervous System), cardiology, urology, and endocrinology.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U24239MH1995PTC092028 |
| Company No. | 092028 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 22 Aug 1995 |
| Date of AGM | 16 Dec 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Mumbai |
Financials of Mega Fine Pharma Private Limited
Mega Fine Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.89% decrease. The company also saw a substantial fall in profitability, with a 39.57% decrease in profit. The company's net worth Soared by an impressive increase of 13.51%.
Enhance accessibility to Mega Fine Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Mega Fine Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Mega Fine Pharma Private Limited
Unlock and access historical data on people associated with Mega Fine Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Nov 2019 | ₹44.50 Cr | Open |
Hdfc Bank Limited Creation Date: 26 Apr 2012 | ₹26.99 Cr | Open |
State Bank Of India Creation Date: 13 Jun 2006 | ₹62.14 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mega Fine Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mega Fine Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
7 years 4 months Recent activity within the organization
Annual General Meeting
Mega Fine Pharma Private Limited last Annual general meeting of members was held on 16 Dec 2023 as per latest MCA records.
16 Dec 2023Balance Sheet
Mega Fine Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge with Hdfc Bank Limited of Rs. 26.99 cr registered on 26 Apr 2012 with Charge ID 10350830 was modified on 15 Jan 2021.
15 Jan 2021Charges
A charge with Hdfc Bank Limited amounted to Rs. 44.50 cr with Charge ID 100304683 was registered on 22 Nov 2019.
22 Nov 2019Director Appointment
Kunal Ashok Jhaveri was appointed as a Director was appointed as a Director on 24 Dec 2018 & has been associated with this company since 5 years 4 months .
24 Dec 2018
Recent News, Updates & Announcement
Indian IT czar Azim Premjis family office in talks to back Megafine Pharma.Shareandstocks 29 Feb 2024
- USFDA Issues Warning to Megafine Pharma Over Violations at Vapi Facility in Gujarat.
USFDA to Megafine Pharma Your Vapi facility in Gujarat has major violations of good manufacturing norms You used bad materials and didnt clean equipment properly Your test methods cant prove drug purity Your quality system is not reliable Fix everything or we wont approve your new drugs Keep this up and we wont let your drugs into the US.
Economic Times 11 Mar 2023
- USFDA issues warning letter to Megafine Pharma for Vapi plant.
BusinessFortNight 09 Mar 2017
Frequently asked questions
What is the Incorporation or founding date of Mega Fine Pharma Private Limited?
